A Novel Therapeutic Approach for the Elimination of Harmful Bacteria From the Microbiome

Time: 1:45 pm
day: Day 2 - Track A Evening

Details:

  • Learn the development of Eligobiotics(r): a new class of phage-derived antimicrobials with unparalleled specificity
  • EB003: an Eligobiotic(r) for the treatment of Shiga toxin-producing E.coli
  • Eligobiotics(r) as novel Gene Therapy products allowing precise intervention on the microbiome

Speakers: